This 1-day medical cancer conference will focus on the 'medical' late effects of cancer treatments and provide a forum to discuss best practice.
Data shows that 40–45% of people should expect a cancer diagnosis in their lifetime. The number of patients who have survived cancer is also growing and so it is estimated that some 500,000 people are living with the actual and long-term consequences of cancer therapy.
With these statistics and with an ageing population, it is increasingly likely that all physicians will see patients who have survived cancer and are living with the late effects.
Really good, high quality conference with lots of ideas and thoughts to take back to my colleagues.
We invite submissions of abstracts to be considered for poster presentation at the conference. All successful abstracts must be presented at the conference at an attended poster session. Therefore, at least one member of the team submitting the abstract will be expected to register and pay as a full delegate.
Abstracts may be published in print or online. By submitting an abstract, authors are agreeing to publication.
Abstracts should be submitted by email to email@example.com by midnight on 18 July 2016, accompanied by an abstract submission form. For further details please download the documents at the bottom of the page. For clinical cases please use the clinical case abstract template.
This workshop is co-badged by:
The RCP thanks Macmillan Cancer Support as its principal partner.
The RCP runs a comprehensive programme of conferences on a wide range of topics, offering delegates: